Steadymed Cash Flow - Annual (NASDAQ:STDY)

Add to My Stocks
$4.73 $0 (0%) STDY stock closing price Aug 30, 2018 (Closing)

The financial analysis of STDY requires an investor to check the cash flows for Steadymed. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Steadymed profits one has to check the income statement and for Steadymed debt one has to check the balance sheet. Steadymed cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Steadymed had cash and cash equivalents of $23.21M at the beginning of the year and $32.45M at year end for 2017. Steadymed has a positive cash and cash equivalents change of $9.23M.

View details of Steadymed cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
-23.2M-25.86M-24.97M-19.04M-7.85M
Depreciation Depletion Amortization Cash-Flow-----
Net Increase (Decrease) in Assets Liabilities-4.04M-2.11M2.29M-
Cash From (used in) Discontinued Operations-----
Other Adjustments Net4.21M-0.87M-3.16M-0.43M
Net Cash from (used by) Operating Activities
-22.24M-25.85M-21.57M-13.37M-7.53M
Increase (Decrease) in Prop Plant And Equipment-1.71M-2.38M-1.88M-0.94M-0.33M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments--0.06M-0.01M--0.01M
Other Cash Inflow (Outflow) from Investment Activities-----1.7M
Net Cash from (used by) Investment Activities
-1.66M-2.13M-1.19M-0.24M-2.04M
Issuance (Purchase) of Equity Shares33.14M19.58M49.01M19.2M2.57M
Issuance (Repayment) of Debt Securities--0.23M-0.56M-0.56M1.33M
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities----0.93M-
Net Cash from (used by) Financing Activities
33.14M19.35M48.45M17.71M3.91M
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
9.23M-8.63M25.68M4.09M-5.66M
Cash & Equivalents at Beginning of Year23.21M31.85M6.16M2.07M7.74M
Cash & Equivalents at Year End32.45M23.21M31.85M6.16M2.07M
All figures in USD. M: Millions of USD, B: Billions of USD.

While Steadymed stock price history provides the price history of a stock, Steadymed stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Steadymed had a Net Change in Cash and Cash Equivalents of $9.23M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Steadymed stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • The cash generated from the core business or operations was a negative at $-22.24M for Steadymed in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash from investing stood at a negative value of $-1.66M for STDY stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Steadymed earned $33.14M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Steadymed Cash Flow

FCF margin
0